Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

CONSTELLATION PHARMACEUTICALS INC Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues32.627.9
            Revenue growth17.0% 
Cost of goods sold39.133.7
Gross profit-6.5-5.8
            Gross margin-19.8%-20.7%
General and administrative6.55.8
EBIT-39.1-33.7
            EBIT margin-119.8%-120.7%
Pre-tax income-35.4-34.5
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-0.10.0
            Net margin-0.2%-0.2%
 
Diluted EPS($56.12)($53.19)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy